Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

RxSight, Inc. - Common Stock (NQ:RXST)

9.570 -0.050 (-0.52%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 8, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	552,230
Open	9.620
Bid (Size)	9.500 (100)
Ask (Size)	9.610 (100)
Prev. Close	9.620
Today's Range	9.520 - 9.790
52wk Range	6.320 - 35.60
Shares Outstanding	33,981,877
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST

January 06, 2026

From Pomerantz LLP

Via GlobeNewswire

RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference

January 02, 2026

From RxSight, Inc.

Via GlobeNewswire

Performance

YTD	-7.8%	-7.8%
1 Month	-23.3%	-23.3%
3 Month	+18.0%	+18.0%
6 Month	+13.1%	+13.1%
1 Year	-72.3%	-72.3%

More News

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST

December 30, 2025

From Pomerantz LLP

Via GlobeNewswire

Earnings Scheduled For November 5, 2025 ↗

November 05, 2025

Via Benzinga

RxSight, Inc. Announces Chief Financial Officer Transition

December 22, 2025

From RxSight, Inc.

Via GlobeNewswire

RxSight, Inc. to Present at the Piper Sandler Healthcare Conference

November 20, 2025

From RxSight, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

November 06, 2025

Via Benzinga

Wondering what's happening in today's after-hours session? ↗

November 05, 2025

Via Chartmill

RxSight, Inc. Reports Third Quarter 2025 Financial Results

November 05, 2025

From RxSight, Inc.

Via GlobeNewswire

Integer Holdings (ITGR) Shares Plunge 31.4% as Slower New Product Adoption and Revised Guidance Rock Investor Confidence

October 23, 2025

Via MarketMinute

RxSight, Inc. to Report Third Quarter 2025 Financial Results on November 5, 2025

October 22, 2025

From RxSight, Inc.

Via GlobeNewswire

RxSight, Inc. to Feature Live Learning Sessions at American Academy of Ophthalmology 2025 Annual Meeting

October 16, 2025

From RxSight, Inc.

Via GlobeNewswire

RXSIGHT ALERT: Bragar Eagel & Squire, P.C. is Investigating RxSight, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

October 08, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight

September 22, 2025

From Faruqi & Faruqi, LLP

Via Business Wire

RXSIGHT FINAL DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Urges RXST To Contact the Firm Regarding Class Action Lawsuit

September 22, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

RxSight, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - RXST

September 22, 2025

Via NewMediaWire

RxSight, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - RXST

September 22, 2025

Via TheNewswire.com

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight

September 21, 2025

From Faruqi & Faruqi LLP

Via GlobeNewswire

Deadline Soon: RxSight, Inc. (RXST) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit

September 19, 2025

From The Law Offices of Frank R. Cruz

Via Business Wire

RXSIGHT DEADLINEALERT: Bragar Eagel & Squire, P.C. Reminds RXST Investors that a Class Action Lawsuit Has Been Filed Against RxSight, Inc. and Encourages Investors to Contact the Firm Before September 22nd

September 19, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

Levi & Korsinsky Reminds RxSight, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 22, 2025 - RXST

September 19, 2025

Via NewMediaWire

Levi & Korsinsky Reminds RxSight, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 22, 2025 - RXST

September 19, 2025

Via TheNewswire.com

Levi & Korsinsky Reminds RxSight, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 22, 2025 - RXST

September 18, 2025

Via NewMediaWire

Levi & Korsinsky Reminds RxSight, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 22, 2025 - RXST

September 18, 2025

Via TheNewswire.com

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight

September 17, 2025

From Faruqi & Faruqi LLP

Via GlobeNewswire

Frequently Asked Questions

Is RxSight, Inc. - Common Stock publicly traded?

Yes, RxSight, Inc. - Common Stock is publicly traded.

What exchange does RxSight, Inc. - Common Stock trade on?

RxSight, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for RxSight, Inc. - Common Stock?

The ticker symbol for RxSight, Inc. - Common Stock is RXST on the Nasdaq Stock Market

What is the current price of RxSight, Inc. - Common Stock?

The current price of RxSight, Inc. - Common Stock is 9.570

When was RxSight, Inc. - Common Stock last traded?

The last trade of RxSight, Inc. - Common Stock was at 01/08/26 04:00 PM ET

What is the market capitalization of RxSight, Inc. - Common Stock?

The market capitalization of RxSight, Inc. - Common Stock is 325.21M

How many shares of RxSight, Inc. - Common Stock are outstanding?

RxSight, Inc. - Common Stock has 325M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.